Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIMH

Glycolipid Enzyme Polymer Conjugates

  • Read more about Glycolipid Enzyme Polymer Conjugates
The Netherlands
94903530.7
Filed on 1993-12-08

Identification of Polymorphisms in the PCTG4 Gene

  • Read more about Identification of Polymorphisms in the PCTG4 Gene
US Patent 6,566,061
Filed on 2000-01-26

Tyrosine-DNA Phosphodiestrerases(TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cells, Antibodies...

  • Read more about Tyrosine-DNA Phosphodiestrerases(TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cells, Antibodies...
Patent Cooperation Treaty
PCT/US00/27400
Filed on 2000-10-05

Parathyroid Hormone Receptor Ligands

  • Read more about Parathyroid Hormone Receptor Ligands
Patent Cooperation Treaty
PCT/US00/16776
Filed on 2000-06-15

COMPOSITIONS CONTAINING IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION FOR INDUCING IMMUNE TOLERANCE TO A GRAFT

  • Read more about COMPOSITIONS CONTAINING IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION FOR INDUCING IMMUNE TOLERANCE TO A GRAFT
Patent Cooperation Treaty
PCT/US00/10253
Filed on 2000-04-14

High Sensitivity Phage Display Biomolecule Detection

  • Read more about High Sensitivity Phage Display Biomolecule Detection
Patent Cooperation Treaty
PCT/US00/10146
Filed on 2000-04-13

Displacement of a Defective Mitochondrial DNA Gene Product by a Nondefective Gene Product of the Nuclear Genome

  • Read more about Displacement of a Defective Mitochondrial DNA Gene Product by a Nondefective Gene Product of the Nuclear Genome
Patent Cooperation Treaty
PCT/US00/06037
Filed on 2000-03-08

Immunotoxin Fusion Proteins and Means For Expression Thereof

  • Read more about Immunotoxin Fusion Proteins and Means For Expression Thereof
US Application 09/573,797
Filed on 2000-05-18

METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28

  • Read more about METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28
Patent Cooperation Treaty
PCT/US00/00284
Filed on 2000-01-06

NOVEL VECTORS AND EXPRESSION METHODS FOR PRODUCING MUTANT PROTEINS07162003

  • Read more about NOVEL VECTORS AND EXPRESSION METHODS FOR PRODUCING MUTANT PROTEINS07162003
US Application 09/380,483
Filed on 2000-03-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 63
  • Page 64
  • Page 65
  • Page 66
  • Page 67
  • Page 68
  • Page 69
  • Page 70
  • Page 71
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIMH
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health